4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-003531
Co-Chief Executive Officer sold 7,471 shares at $4.05 ($30,232)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2025-01-06 | Sale | −7,471 | $4.05 | $30,232 | 3,213,098 | D |
| Open-market sales · 7,471 sh · avg $4.05 · $30,232 | |||||||
Loading xslF345X05/ownership.xml…